“The scientific community is now recognizing decades of our research and development showing that ParActin® with its andrographolides have great potential to be the next new class of anti-inflammatory agents”.
-Annie Eng, Founder & CEO/President of HP Ingredients
This site is business-to-business only, please note that it is not designed for end-consumer use. This material is meant for professional product development informational purposes only and is not intended for the treatment or diagnosis of diseases, which should be done by a healthcare professional. This website is not intended to provide medical advice. Statements about the health benefits of ParActin have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.